① China Investment Corporation's 2024 business management work conference revealed that it will promote the construction of Huijin's “three major platforms” and enrich and upgrade equity management tools. Affected by this, Huajin Capital rose and stopped strongly today. ② Among foreign investments, advanced manufacturing and healthcare are the areas where Huajin Capital invests the most. Up to now, Huajin Capital has invested in 12 listed companies, including Preferred Choice and NARI Radar.
“Science and Technology Innovation Board Daily”, January 16 (Reporter Chen Mei) Huajin Capital rose strongly today due to news that China Investment Corporation held a 2024 business management work conference, which emphasized promoting the construction of Huijin's “three major platforms” and enriching and upgrading equity management tools.
Equity penetration shows that Huajin Capital is an investment and asset management company. The majority shareholder is Zhuhai Huafa Technology Industry Group, which is a state-owned capital operating group backed by the Zhuhai Huafa Group under the Zhuhai State-owned Assets Administration Commission.
Faced with today's rise and fall, the “Science and Technology Innovation Board Daily” reporter telephoned Huajin Capital. The board and secretary's office staff said that the rise and fall in stock prices was a market reaction. According to the source, “Previously, the market expected Huajin Securities to be injected into the company, but there really is no news related to this that can be released.”
According to data from the Financial Association Venture Capital Connect - Central Administration, Huajin Capital currently manages 70 funds, including venture funds, early-stage funds, and market-based FOFs. In terms of foreign investment, it has now invested in 104 companies. Series A, B and equity investments are the main investment stages of this institution.
Advanced manufacturing, healthcare, etc. are the areas where Huajin Capital invests the most. The staff mentioned above also said, “Semiconductors, new energy, and biomedicine are important investment areas for the company, and they have not changed.”
In terms of investment regions, Huajin Capital is involved in a wide range of regions, and the investee companies are distributed all over the country. The most recent investment is Yiling Biotech.
According to financing data, Huajin Capital participated in the company's Series B financing with Ceyuan Capital, Precision Medicine Industry Innovation Fund, Hi-Tech Development, Chengdu Venture Capital, and Sichuan Venture Capital. Previously, the company had received angel round investment from Guizhou Bailing, as well as Series A investment from Sichuan Development, Sichuan Venture Capital, and Tianfu International Biotech City.
In addition, Anmuquan, Penghui Energy, Huaqing Electronics, and Belai Pharmaceutical are also investment projects in which Huajin Capital participated.
**Up to now, Huajin Capital has invested in 12 listed companies including Preferred Choice, Mengguli, Jingsheng Co., Ltd., and Narui Radar.
According to the official website of China Investment Corporation, China Investment Group will thoroughly plan the investment and operation of state-owned financial capital, play an integrated role as a platform for risk management and market stability, and further strengthen, improve, and expand state-owned financial capital.
A private equity investor told the “Science and Technology Innovation Board Daily” reporter that some important areas are invested by state-owned capital, such as the construction of new infrastructure to further promote high-end, intelligent, and green development. On the other hand, this aspect is a need for innovation-driven development strategies; on the other hand, it is also the proper investment direction for state-owned capital to better serve the country's strategic needs, adjust the stock structure, and optimize incremental growth.